🇺🇸 FDA
Patent

US 6489163

Ribozyme mediated inactivation of the androgen receptor

expired A61KA61K38/00

Quick answer

US patent 6489163 (Ribozyme mediated inactivation of the androgen receptor) held by The Board of Regents of the University of Texas System expires Mon Nov 28 2022 00:00:00 GMT+0000 (Coordinated Universal Time). Status: expired.

Key facts

Applicant
The Board of Regents of the University of Texas System
Grant date
Tue Dec 03 2002 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Nov 28 2022 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
21
CPC classes
A61K, A61K38/00